BioCatalyst

JSPR — Jasper Therapeutics, Inc. catalysts

2 verified catalyst event(s) for Jasper Therapeutics, Inc. (ticker JSPR). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-13 — A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-13
in 2mo
ESTIMATED
 READOUT
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical
Phase 2 · Urticaria Chronic
 JSPR Jasper Therapeutics, Inc. Briquilimab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-10-31
in 4mo
ESTIMATED
 READOUT
Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary
Phase 1/2 · Chronic Spontaneous Urticaria
 JSPR Jasper Therapeutics, Inc. Briquilimab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.